You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 19, 2025

Suppliers and packagers for generic pharmaceutical drug: fluocinolone acetonide; hydroquinone; tretinoin


✉ Email this page to a colleague

« Back to Dashboard


fluocinolone acetonide; hydroquinone; tretinoin

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Galderma Labs Lp TRI-LUMA fluocinolone acetonide; hydroquinone; tretinoin CREAM;TOPICAL 021112 NDA Galderma Laboratories, L.P. 0299-5950-02 1 TUBE in 1 BLISTER PACK (0299-5950-02) / 3 g in 1 TUBE 2002-01-18
Galderma Labs Lp TRI-LUMA fluocinolone acetonide; hydroquinone; tretinoin CREAM;TOPICAL 021112 NDA Galderma Laboratories, L.P. 0299-5950-30 1 TUBE in 1 CARTON (0299-5950-30) / 30 g in 1 TUBE 2002-01-18
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drugs: Fluocinolone Acetonide, Hydroquinone, and Tretinoin

Last updated: July 29, 2025


Introduction

The pharmaceutical market consists of a diverse pool of suppliers manufacturing and distributing critical active pharmaceutical ingredients (APIs). Among these, fluocinolone acetonide, hydroquinone, and tretinoin are prominent compounds used in dermatology and other therapeutic areas. Accurate sourcing is vital for pharmaceutical companies, given the strict regulatory landscape, quality standards, and supply chain reliability. This report identifies leading suppliers for these drugs, analyzes their market positioning, and provides strategic insights for stakeholders.


Fluocinolone Acetonide Suppliers

Overview

Fluocinolone acetonide is a potent synthetic corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive properties. It finds applications mainly in topical formulations for dermatitis, psoriasis, and other inflammatory skin conditions.

Key Suppliers

  1. Xianju Pharmaceutical Co., Ltd. (China)
    A prominent regional manufacturer, Xianju produces fluocinolone acetonide for global markets. With WHO GMP certification, they supply APIs in bulk to multinational pharmaceutical companies.

  2. YZH Pharmaceutical (China)
    Specializing in corticosteroids, YZH offers high-quality fluocinolone acetonide with consistent batch performance. Their scalable production capacity supports large-volume needs.

  3. Bayer AG (Germany)
    Although primarily a finished dosage form producer, Bayer maintains a robust API division with high purity corticosteroids, including fluocinolone acetonide, aligned with European Union standards.

  4. MINE Pharmaceutical (India)
    A key player in the Indian API market, Mine supplies fluocinolone acetonide and has ISO certifications. Their products are often used in generics and branded formulations globally.

Market Trends

Chinese manufacturers dominate global API supplies, driven by cost competitiveness and increasing pharmaceutical manufacturing capacity. Regulatory compliance (e.g., cGMP, ISO) remains critical for international procurement.


Hydroquinone Suppliers

Overview

Hydroquinone is a skin-lightening agent used predominantly in depigmentation therapies and cosmetic formulations. Its global demand is influenced by regulatory scrutinies, especially concerning safety.

Key Suppliers

  1. Yamato Rasayan India Ltd. (India)
    The company offers pharmaceutical-grade hydroquinone, adhering to international standards. Their manufacturing plants are WHO-GMP certified.

  2. BASF SE (Germany)
    As a leading chemical producer, BASF supplies high-quality hydroquinone with consistent purity profiles, mainly serving cosmetic and pharmaceutical clients.

  3. Shaanxi Fuheng (F H) Biotechnology Co., Ltd. (China)
    A significant Chinese API supplier, F H Biotechnology provides hydroquinone for both pharmaceutical and cosmetic applications, with certifications aligned with international regulations.

  4. Miyakoda Fine Chemical (Japan)
    Known for high-purity chemicals, the Japanese supplier serves premium markets, emphasizing strict quality controls.

Regulatory Considerations

Hydroquinone's usage faces regulatory restrictions in several jurisdictions; for example, the U.S. FDA limits OTC products containing hydroquinone to 2%. Suppliers emphasizing regulatory compliance are preferred.


Tretinoin Suppliers

Overview

Tretinoin, also known as all-trans retinoic acid, has broad dermatological applications, especially in acne treatment and acute promyelocytic leukemia therapy. Its high requirement for purity necessitates sourcing from reputable suppliers.

Key Suppliers

  1. Nagara Pharma Corporation (India)
    A leading Indian API manufacturer offering pharmaceutical-grade tretinoin, with a focus on high purity (>98%) and stability profiles.

  2. Hangzhou Sunflower Pharmaceutical & Chemical Co., Ltd. (China)
    A significant supplier with a globally compliant manufacturing process, providing tretinoin APIs for prescription products.

  3. BASF SE (Germany)
    Again a prominent chemical supplier, BASF offers high-purity tretinoin, supporting both pharmaceutical and research applications.

  4. Jiangsu Hengrui Medicine Co., Ltd. (China)
    A rapidly growing provider in the API market, Hengrui supplies tretinoin that complies with stringent pharmaceutical standards.

Market Dynamics

Asia remains the primary source of tretinoin APIs due to cost advantages and manufacturing capacity. Quality certifications such as ISO and cGMP are critical markers for reliable suppliers.


Strategic Sourcing Considerations

  • Regulatory Compliance: Suppliers must meet cGMP, US FDA, EMA, or WHO standards depending on the target market.
  • Quality Assurance: High purity, consistent batch-to-batch reproducibility, and comprehensive quality documentation are non-negotiable.
  • Supply Chain Reliability: Long-term partnerships with diversified suppliers mitigate risks associated with geopolitical shifts or manufacturing disruptions.
  • Cost Efficiency: While cost remains a significant factor, it should align with quality standards and regulatory expectations.

Conclusion

The global landscape for fluocinolone acetonide, hydroquinone, and tretinoin suppliers reveals a concentration of reputable manufacturers across China, India, and Europe. Market players prioritizing high regulatory compliance, consistent quality, and supply reliability will secure competitive advantages. Chinese and Indian manufacturers dominate due to scale and cost, but partnerships with European suppliers like BASF can enhance quality assurance, especially for regulatory-sensitive markets.


Key Takeaways

  • Diversify supplier base to reduce dependency risks, especially given regulatory uncertainties and geopolitical factors.
  • Prioritize suppliers with robust quality certifications, including cGMP, ISO, and WHO certificates.
  • Monitor regulatory landscapes, particularly for hydroquinone, due to evolving safety regulations worldwide.
  • Leverage supplier relationships for favorable pricing and priority access in supply chain disruptions.
  • Align procurement strategies with evolving patent statuses and market demands to optimize product lifecycle management.

FAQs

1. Are there regulatory restrictions on sourcing hydroquinone globally?
Yes. Hydroquinone faces varying regulatory controls; the U.S. restricts OTC products to 2% concentration, and several countries have banned or limited its cosmetic usage due to safety concerns. Suppliers must comply with local regulations and provide documentation for approval in target markets.

2. Which regions dominate the supply of fluocinolone acetonide?
China is the primary global supplier, followed by India and Europe. Chinese manufacturers benefit from large-scale production and cost advantages, while European firms tend to meet higher regulatory standards.

3. How can companies ensure the quality of tretinoin APIs?
By sourcing from suppliers with proven compliance to cGMP, ISO standards, and extensive quality documentation. Quality audits and vendor qualification processes are essential.

4. What are the key factors influencing supplier selection for these APIs?
Quality assurance, regulatory compliance, supply chain reliability, pricing, and past delivery performance are paramount.

5. Are there any upcoming regulatory changes that could impact API sourcing?
Global regulatory agencies continually review safety profiles of these drugs, especially hydroquinone. Changes in classification, limits, or bans can influence supplier availability and sourcing strategies.


References

  1. [1] World Health Organization. "Prequalification Programme Medicines." WHO.
  2. [2] US Food and Drug Administration. "Regulatory Overview of Hydroquinone." FDA.gov.
  3. [3] European Medicines Agency. "Guidelines for Topical Corticosteroids." EMA.
  4. [4] Market Research Reports. "API Market Insights." Global Industry Analysts.
  5. [5] Company Websites and Certifications.

Note: The above references are indicative and should be supplemented with current, authoritative industry reports and regulatory updates for procurement decisions.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.